Who Owns Kairos Pharma Stock?
NYSE: KAPAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 0.93 +0.30%
Ownership breakdown
- Held by institutions
- 7.82%
- Held by insiders
- 33.61%
- Institutional holders
- 16
- Institutions 7.8%
- Insiders 33.6%
- Public and other 58.6%
Who owns Kairos Pharma stock?
Institutional investors own about 7.8% of Kairos Pharma's shares, spread across 16 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 33.61% of KAPA.
The largest institutional holders are Citadel Advisors Llc (0.19%), Vanguard Capital Management LLC (0.14%) and Virtu Financial LLC (0.05%). Together, the top 10 institutions control 0.6% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their KAPA positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of KAPA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Citadel Advisors Llc | 44.26K | 0.19% | +100.0% |
| Vanguard Capital Management LLC | 33.13K | 0.14% | 0.0% |
| Virtu Financial LLC | 11.73K | 0.05% | +100.0% |
| Geode Capital Management, LLC | 11.28K | 0.05% | -29.1% |
| Vanguard Fiduciary Trust Co | 9.13K | 0.04% | 0.0% |
| Aptus Capital Advisors, LLC | 6.33K | 0.03% | 0.0% |
| SevenBridge Financial Group, LLC | 6.33K | 0.03% | 0.0% |
| Jane Street Group, LLC | 4.82K | 0.02% | +100.0% |
| Susquehanna International Group, LLP | 4.18K | 0.02% | +100.0% |
| State Street Corporation | 3.44K | 0.01% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of KAPA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 23.42K | 0.10% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 9.71K | 0.04% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 6.97K | 0.03% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 1.09K | 0.00% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 5 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Kairos Pharma?
Citadel Advisors Llc is the largest institutional shareholder of KAPA, owning 0.19% of shares outstanding (44.26K shares) as of its latest 13F filing.
What percentage of Kairos Pharma is owned by institutions?
Institutions own about 7.8% of KAPA shares and 11.8% of the public float.
How much of Kairos Pharma do insiders own?
Insiders, such as officers and directors, own about 33.61% of KAPA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.